Genetic Background Influences Susceptibility to Chemotherapy-Induced Hematotoxicity

por Gatti, Daniel M., Weber, Susanne N., Goodwin, Neal C., Lammert, Frank, Churchill, Gary A.
Publicado 2017

A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies

por Hooper, Jody E., Cantor, Emma L., Ehlen, Macgregor S., Banerjee, Avirup, Malempati, Suman, Stenzel, Peter, Woltjer, Randy L., Gandour-Edwards, Regina, Goodwin, Neal C., Yang, Yan, Kaur, Pali, Bult, Carol J., Airhart, Susan D., Keller, Charles
Publicado 2015

Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide

por Rodrigueza, Wendi V., Woolliscroft, Michael J., Ebrahim, Abdul-Shukkur, Forgey, Robert, McGovren, Patrick J., Endert, Gerold, Wagner, Andreas, Holewa, Danielle, Aboukameel, Amro, Gill, Richard D., Bisgaier, Charles L., Messmann, Richard A., Whitehead, Christopher E., Izbicka, Elzbieta, Streeper, Robert, Wick, Michael C., Stiegler, Gabriela, Stein, C. A., Monsma, David, Webb, Craig, Sooch, Mina P., Panzner, Steffen, Mohammad, Ramzi, Goodwin, Neal C., Al-Katib, Ayad
Publicado 2014

Preclinical rationale for entinostat in embryonal rhabdomyosarcoma

por Bharathy, Narendra, Berlow, Noah E., Wang, Eric, Abraham, Jinu, Settelmeyer, Teagan P., Hooper, Jody E., Svalina, Matthew N., Bajwa, Zia, Goros, Martin W., Hernandez, Brian S., Wolff, Johannes E., Pal, Ranadip, Davies, Angela M., Ashok, Arya, Bushby, Darnell, Mancini, Maria, Noakes, Christopher, Goodwin, Neal C., Ordentlich, Peter, Keck, James, Hawkins, Douglas S., Rudzinski, Erin R., Mansoor, Atiya, Perkins, Theodore J., Vakoc, Christopher R., Michalek, Joel E., Keller, Charles
Publicado 2019